Contineum Therapeutics, Inc. (CTNM)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-23.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | — | $0 | $50.00M | — |
| Operating Income | -$68.06M | -$50.89M | $16.08M | — |
| Net Income | -$59.98M | -$42.26M | $22.72M | — |
| EPS (Diluted) | $-2.17 | $-2.18 | $0.08 | — |
| Total Assets | $276.64M | $212.85M | $130.39M | — |
| Total Liabilities | $15.65M | $14.78M | $5.70M | — |
| Shareholders' Equity | $260.99M | $198.07M | -$67.94M | -$93.21M |
| Cash & Equivalents | $75.60M | $21.94M | $15.53M | — |
| Operating Cash Flow | -$55.31M | -$32.84M | $19.35M | — |
| Capital Expenditures | $231.0K | $514.0K | $414.0K | — |
| Shares Outstanding | 27.70M | 19.35M | 3.40M | — |